All posts by imreal

This Naked Mind Launches Unprecedented Program for Anyone Wanting Help Around Alcohol, Anxiety, Fear


News Image

Right now, people are afraid, but they have a choice. They can run and hide, or they can embrace the opportunity to show up and ask the right questions. In this isolating time, we need connection now more than ever; we don’t want anyone to feel alone.

Just because the liquor stores are staying open, you don’t have to drink. Just because you got invited to five virtual “quarantini” happy hours in your friends’ Zoom rooms this week, you don’t have to drink. Just because social media makes it feel like absolutely everyone is boozing 24/7 to survive the COVID-19 pandemic, you don’t have to drink.

That’s what This Naked Mind (TNM) wants people to know. And, it’s the reason a brand new free program called TNM Connection launched earlier this week. TNM Connection is for anyone who is drinking. It’s also for anyone who isn’t drinking but wishes they were. And, it’s for anyone who’s feeling on edge. Whether or not people are simply thinking about alcohol or actually consuming it, TNM Connection offers tools to help quiet their minds, quiet some of their fears, and teach them how to take a breath and find a moment of peace any time they need it.

“Alcohol sales are skyrocketing right now,” says Annie Grace, founder of This Naked Mind and author of This Naked Mind: Control Alcohol, Find Freedom, Discover Happiness & Change Your Life and The Alcohol Experiment: A 30-day, Alcohol-Free Challenge to Interrupt Your Habits and Help You Take Control. “People are day drinking like never before, starting with vodka in their morning coffee. Why? Because they’re doing the best they can with the tools they have. As a society, we have traditionally used alcohol to manage fear and anxiety.”

TNM Connection offers science-based methods that really work. Naked Mind certified coaches are volunteering their time daily for hours of live group coaching. And, they’ll continue for as long as it’s needed. This is a program like no other, because we’re experiencing a challenge like none we’ve ever seen before.

“Right now, people are afraid, but they have a choice,” says Annie Grace. “They can run and hide, or they can embrace the opportunity to show up and ask the right questions. In this isolating time, we need connection now more than ever; we don’t want anyone to feel alone.”

Unlike most “stop drinking” programs, TNM Connection isn’t just about alcohol. The TNM ACT Technique helps people find peace in so many different areas of their lives. No matter what they may be feeling, people can pinpoint a thought or belief and make a positive change within minutes. There’s no judgment, shame, or blame. Just compassion and connection.

Those who wish to explore this invaluable yet free resource are invited to visit TNM Connection to learn more and join.

About This Naked Mind

Founded by Annie Grace in 2015, This Naked Mind (TNM) helps people end the conflict between their desire to drink less and their unconscious belief that alcohol is beneficial, Annie Grace overcame a decade of drinking by revamping her own relationship with alcohol. Today she helps others across the globe do the same – the 200,000+ people who’ve bought her books, the 350,000+ people who receive daily emails from her, the listeners who’ve downloaded her This Naked Mind Podcast episodes more than 4 million times, and the 110,000+ people who’ve gone through her free program, The Alcohol Experiment. Rather than teaching people how to be sober, TNM takes away the desire to drink. And, the approach helps people where rehabs have not. Join TNM on Facebook, Instagram, YouTube, Twitter, LinkedIn, and Pinterest.

Share article on social media or email:



Can Nutritional therapy and IPL help with Rosacea?


What is Rosacea?

Rosacea is a condition often misdiagnosed and the causes of this condition is poorly understood. It manifests on the face, especially the cheeks, chin, nose and mid forehead. Although it is not a life threatening condition, it can cause enormous social and psychological problems.

The condition develops gradually. Mild episodes of facial blushing or flushing can lead to a permanent red face. Individuals with fair skin, particularly those of Scottish, Irish or Celtic descent are more predisposed to Rosacea. This condition is commonly known as ‘The curse of the Celts’; although people with darker skins also suffer from Rosacea. Rosacea is more common in women than men and women often develop it earlier in life. However, the condition is generally more severe in men where changes to the texture of the skin, skin thickening and a bulbous enlarged nose may occur(Rhinophyma).

What causes it:

The causes of rosacea is not clearly understood, there are several possibilities but are unproven. There appears to be genetic and environmental factors involved in Rosacea. Frequently there is a history of family members having this condition. Some of the proposed possibilities are vascular irregularities, facial mites & bacteria, the use of steroids and other environmental factors. Hormonal imbalances in perimenopausal women may be a causative factor in vascular instability.

Studies in 1999- 2000 suggested a link between Helicobacter Pylori infection and rosacea. Another theory proposed was the existence of Demodex Folliculorum ( facial mites) as a possible cause. The mite colonizes enlarged Sebaceous follicles that are found in rosacea sufferers.

There are numerous triggers for rosacea flare ups, these can be caused by certain foods, environmental factors such as excessive heat, common medications or other medical conditions.

Nutritional therapy & IPL technology

A Rosacea sufferer will approach a consultation with great trepidation. They will most likely have already seen various doctors and have had numerous treatments recommended by their GP or dermatologist, all to no avail.

IPL becomes the last resort, so by the time the client approaches us they have usually adopted a negative mind-set regarding rosacea treatments. Therefore it is important to address the emotional distress that the person is feeling. Our duty of care in the first instance is to reassure them that they can be helped.

We conduct a full assessment of each clients condition and needs based on the knowledge and experience we have gained over the past decade. There are different wavelengths used and detailed information on how many passes on the face will be done on each treatment. A course of 6 treatments lasting 40 minutes is suggested, spaced 3-4 weeks apart. An area of the face, normally the jaw line is selected for a patch test. More than one wavelength is used in the patch test.

At the Pulse Light Clinic, we have evolved a successful IPL technique using different wavelengths of light to address various aspects of the condition ranging from the vascular components to facial mites. Using the most advanced IPL technology available, The Lumenis M22 IPL machine is capable of producing spectacular results without any downtime, after effects or complications that was once associated with IPL.

Conclusion:

The combination of nutritional therapy and intense pulsed light technology is a safe highly versatile and effective method for the treatment of Rosacea.

The appropriate use of the wavelengths involved in this technology coupled with the technical ability and experience of the practitioner is vital to achieving optimum results.

A mere cosmetic approach to this condition will not suffice, rather years of research, training, expertise and commitment to obtaining long term results is what is required and is the benchmark standard of the Pulse Light Clinic.

Share article on social media or email:

ancora Software Receives US Patent for Automatic Generation of Training Data for Intelligent Document Classification


Providing Advanced Data Capture and Intelligent Document Classification Solutions

“Our document classification automation reduces hundreds of work hours associated with both configuration and production workflows and produces superior results compared to other vendor classification solutions by leveraging machine learning, said Noel Flynn, CEO at ancora software.

ancora Software, the industry leader of Business Process Automation including Intelligent Document Classification and Advanced Data Capture solutions is very happy to announce the issue of a new patent (US 10,607,115) for automatic generation of training data for its previously patented Intelligent Document Classification solution.. This new patent addresses a method of automatic acquisition of training data for any document type with minimal or no human intervention.

ancora’s Document Classification uses a variety of machine learning algorithms and artificial intelligence to address classification and categorization of documents in such diverse applications as Accounts Payable, Sales Order Automation, Mortgage Loan processing, Auto Dealer Loan processing, Mail Room, Medical Records and data management. This breadth of applications is the result of optimally designed features and algorithms that utilize all available information from the documents to be classified such as the size, the layout, logos or pictures, content and any other attributes of the document, just like a human would do if they were scanning documents on their desk and identifying them. ancora also supports connections to downstream systems to validate and verify the results of classification. The software is designed with the degree of automation that supports the ever-increasing levels of simplicity for the users. ancora’s systems take advantage of vector (first generation) PDF documents to bypass OCR and provide unprecedented accuracy of data classification and capture. This results in very high labor savings achieved in all the steps of the document processing workflow. Our largest customer is a financial institution processing over 35 million pages per year with over 900 document types, we are classifying those documents at 98% accuracy.

“Our document classification automation reduces hundreds of work hours associated with both configuration and production workflows and produces superior results compared to other vendor classification solutions by leveraging machine learning, said Noel Flynn, CEO at ancora software. While rules-based approaches are useful for a small number of static document types, only learning-based automated classification offers a solution for more complex classification and separation needs. ancora Document Classification software removes any need to manually identify first, middle and last pages since it analyzes the output of content classification to automatically detect and create rules.

ancoraDocs is available either on premise or as a true multi-tenant cloud service hosted by ancora on Microsoft Azure. It can also be deployed as a hybrid solution, utilizing zero footprint browser-based clients. “ancoraDocs is designed to bring simplicity to a market where applications have historically been complex and overpriced, difficult to configure, install, use, and maintain,” said Nick Bova, VP of Sales at ancora Software. “It can be deployed in a matter of hours or days, not the weeks or months you often see with traditional capture. This helps users start realizing their benefits sooner and produces a faster time to ROI. In addition, it opens the market to SMB organizations, which have historically not been able to take advantage of automated document capture due to the significant costs of getting started.”

About ancora Software

ancora Software, Inc. is an innovative provider of Business Process Automation solutions including Intelligent Document Classification and Data Capture. ancoraDocs, our flagship product, was developed to bring simplicity to a technology that historically has been complex, over-priced, and difficult to configure, install, use and maintain. Our Business Process Automation solutions with patented artificial intelligence and machine learning technologies help companies eliminate costly manual steps in their business processes such as; document classification, document analysis, manual data entry, manual filing, etc. Businesses using ancora Software achieve faster and less expensive business process automation and better controls over valuable critical information. Headquartered in San Diego, CA, ancora Software maintains sales and support operations throughout North America and the UK.

For more information about ancora Software, Inc. visit http://www.ancorasoftware.com

Share article on social media or email:

Sharecare Co-Founders Dr. Oz and Jeff Arnold to Headline First IIS Webinar On COVID-19 Pandemic


“The insurance industry’s response to [the COVID-19] challenge is critical to mitigating loss and supporting recovery. The neutral platform of the IIS positions it as a platform to deliver expert guidance that will inform our industry leaders’ decisions,” said Mike Morrissey, CEO of IIS.

Dr. Mehmet Oz, ten-time Daytime Emmy® Award winner, professor of surgery at Columbia University and co-founder of Sharecare, and Jeff Arnold, co-founder, chairman and CEO of Sharecare, will deliver the first in a series of webinars hosted by the International Insurance Society (IIS) and The Institutes. The series, Leadership Perspective: Global Pandemic, is in response to the COVID-19 global pandemic that has disrupted society across the globe.

Focused on the impact of COVID-19 from the perspective of the insurance sector, the weekly series will highlight thought leadership from a wide range of viewpoints on an array of pandemic issues. These issues will span topics such as wellness and prevention, corporate response and reputational management, underwriting exposures, and investment portfolio management.

The first of this weekly webinar series featuring Dr. Oz and Jeff Arnold will be presented on Monday, March 30th at 1pm EST. In this one-hour session, Arnold and Oz will deliver expert guidance on understanding how the COVID-19 pandemic is reshaping our world and what insurers can do to respond to customer needs as we work to navigate this unprecedented health crisis.

“Few challenges in recent history have required a collective, coordinated response more than the COVID-19 pandemic. As a fundamental pillar of society, the insurance industry’s response to this challenge is critical to mitigating loss and supporting recovery. The neutral platform and convening power of the IIS, comprising all stakeholders of the insurance industry, uniquely positions it as a unique platform to deliver expert guidance that will inform our industry leaders’ decisions in the coming weeks and months,” said Mike Morrissey, CEO of IIS.

About International Insurance Society

IIS serves as the inclusive voice of the industry, providing a platform for both private and public stakeholders to promote resilience, drive innovation, and stimulate the development of markets. The IIS membership is diverse, with members hailing from mature and emerging markets representing all sectors of the re/insurance industry, academics, regulators and policymakers. As a non-advocacy organization, the IIS serves as a neutral platform for active collaboration and examination of issues that shape the future of the global insurance industry. Its signature annual event, the Global Insurance Forum, is considered the premier industry conference and is attended by 500+ insurance leaders from around the globe.

Founded in 1965, the IIS is a 501(c) 3 not for profit organization based in New York, NY. IIS is an affiliate of The Institutes.

About The Institutes | Risk and Insurance Knowledge Group

As the industry’s trusted and respected knowledge leader, The Institutes are committed to meeting the evolving professional development needs of risk management and insurance professionals through innovative research, networking, and career resources. The Institutes offers 28 designations, including the Chartered Property Casualty Underwriter (CPCU®). Other offerings include certificate and introductory programs, online and continuing education courses, leadership education, custom solutions and assessments, and industry consortiums such as the RiskBlock Alliance. TheInstitutes.org.

CPCU is a registered trademark of The Institutes. All rights reserved.

Share article on social media or email:

Major Car Insurance Claim Mistakes That Must Be Avoided


News Image

“Handling a car accident must be done with utmost care. Contact the authorities, take pictures and gather relevant info. And avoid doing the mistakes mentioned in the blog post.” said Russell Rabichev, Marketing Director of Internet Marketing Company

Carinsuranceplan.org has released a new blog post that explains what major mistakes can be done during the car insurance claim process.

For more info and free car insurance quotes, visit http://carinsuranceplan.org/major-car-insurance-claim-mistakes/.

Policyholders who expect a smooth and easy claim process should be prepared with solid proofs that back their claims and avoid making foolish mistakes.


  • Admitting guilt is one of those mistakes that could invalidate ulterior claims. Guilt must be determined by the authorities. Admitting guilt in front of the other driver invalidates ulterior claims. Plus, the insurance company will no longer be able to provide legal defense. Drivers should let the experts decide who is guilty. Some drivers may think they are guilty, but in fact, the other driver was speeding, or crossed the wrong lane or took a wrong turn. Criminalists will be the ones to analyze the circumstances of the accident.
  • Failing to gather proofs is another costly mistake. Drivers should take photos immediately after the accident. This not only will back the driver’s financial claims but will also help the police determine the circumstances of the accident and who is guilty. Take clear photos of the cars, the surrounding area and road conditions.

The blog post presents other costly mistakes and how to avoid them. Being involved in an accident can be a traumatizing experience. A driver should keep his calm and gather sufficient evidence to support his claims.

For more car insurance information and money-saving tips, please visit http://carinsuranceplan.org/.

Carinsuranceplan.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

Share article on social media or email:

Klearly Strengthens Leadership Team With the Addition of Matt Webbink as Chief Product Officer


I’m excited about joining Klearly because our technology is empowering marketing teams of any size to focus on those activities that will positively impact the business and stopping those activities that won’t.

Klearly, the intelligent revenue operations platform, today announced the addition of top technology marketing operations executive Matt Webbink to its executive team. Matt will join Klearly as Chief Product Officer and oversee the company’s product strategy, roadmap, and Voice of the Customer program. Webbink’s appointment comes on the heels of Klearly’s announcement of its $1.5 million round of seed funding.

Prior to joining Klearly, Webbink spent 18 years at Red Hat, the top provider of open source solutions, which was recently acquired by IBM for $34 billion. During his time at Red Hat, Webbink developed and led the expansion of the company’s marketing technology and analytics capabilities, empowering his team of marketers with the tools and insights needed to efficiently and effectively do their jobs.

“Marketing teams have long had to defend their impact on key business outcomes, which hasn’t always been easy, nor highly valued by executive teams,” said Webbink. “I’m excited about joining Klearly because our technology is empowering marketing teams of any size to focus on those activities that will positively impact the business, while stopping those activities that won’t. Democratizing this analytics capability is a natural extension of my Red Hat experience, and I look forward to helping marketing teams put their best foot forward on a smarter path to business growth.”

“Having led marketing operations for one of the most successful, global, B2B tech companies, Matt has significant, first-hand experience with how marketers need better, more actionable data to meet and exceed revenue targets and understand how they’re contributing to the business,” said Alex Krawchick, founder and CEO, Klearly. “We’re thrilled to have Matt on board as we grow the Klearly team, invest in our product, and expand our customer base. Matt’s knowledge of this marketplace is unparalleled and we’re looking forward to his continued contributions.”

Klearly’s SaaS-based platform uses data science and machine learning to help marketing and sales teams quantify how their activities influence revenue, and provides actionable recommendations on future activities. Klearly’s platform helps marketing and sales leaders understand the ideal combinations of activities that will most significantly influence future growth.

About Klearly

Klearly is the revenue operations platform for B2B marketers who desire the smarter path to growth. Headquartered in Durham, NC, Klearly uses data science and machine learning to help marketing and sales teams understand how they’re contributing to the business and prioritize how to most effectively grow the business. Klearly’s SaaS platform identifies the ideal combinations of marketing and sales activities that will most significantly impact future growth. The result is a forward-thinking revenue function armed with the right data to be a more accountable contributor to business growth. Visit http://www.klearly.com or https://www.linkedin.com/company/klearly/ for more information.

Share article on social media or email:

Medopad Offers Support for Global COVID-19 Pandemic


Medopad COVID-19 RPM

Now is the time for global collaboration to help ease the burden of COVID-19 on our healthcare systems, reduce disease spread through remote patient monitoring and maintain the continuity of care for at-risk populations.”

As healthcare systems are overwhelmed in the face of the COVID-19 pandemic, British healthtech company Medopad is offering immediate support by providing its Remote Patient Monitoring (RPM) software at cost to NHS Trusts across the UK and global healthcare providers. Medopad has worked with clinicians from Imperial College, Guys and St Thomas’s NHS Foundation Trust and Johns Hopkins to create a readily available, out-of-box version of its modular RPM platform configured for tracking COVID-19 that can be deployed in days. Through its RPM software, Medopad helps healthcare systems monitor ill and at-risk patients, enable care for chronically ill patients and provide insights to healthcare systems to help them prioritise resources and respond more effectively.

To further support healthcare systems, Medopad is also working with its global partners, including Johns Hopkins and Tencent, to clinically validate digital biomarkers to identify individual patient risk for COVID-19 and monitor respiratory symptoms and disease progression using only a smartphone.

Monitoring COVID-19 Patients and Protecting the Vulnerable

The WHO, NHS, and FDA have formally recommended that healthcare systems use telemedicine and RPM during the COVID-19 public health emergency to reduce the strain on healthcare systems and limit disease spread. Medopad’s clinically validated RPM solutions are secure, infrastructure-ready and scalable to address the demands on healthcare systems and providers, enabling more global understanding of the disease. Medopad’s RPM solution is CE registered and under FDA enforcement discretion and is ready to be deployed in the EU, US, China, Singapore, Hong Kong, Saudi Arabia and beyond for supporting patient care with chronic conditions and configurable for rare diseases.

Medopad’s app and clinician dashboard help track patient data and symptom progression to maintain ongoing patient care and support, flag patients with worsening symptoms and notify clinicians of a patient’s deteriorating health when they are out of the clinical setting. The patient’s mobile app allows them to opt-in to securely share personal health data, including vital signs such as temperature, respiration rate, and heart rate using their smartphone. Medopad has pioneered its RPM solution across fifteen NHS trusts in the UK in the past two years, working with Trusts like Chelsea and Westminster Foundation Trust on diseases like Heart Failure to to reduce the unpredictability of patients presenting at A&E by collecting data and information on heart failure patients when outside of hospital settings.

“As part of the NHSE Test Bed Programme we partnered with Medopad to empower our patients. Through the continuous monitoring of their health, we aim to reduce pressure on A&E and outpatients and avoid hospital admissions and reduce hospital bed days. During the COVID-19 crisis, Medopad’s solution can allow hospitals to continuously monitor and engage with their patients without the need to bring them into the healthcare system where there is an elevated risk of them contracting COVID-19,” commented Felix Vaal, Senior Project Manager for Digital Innovation, Chelsea and Westminster Trust.

Developing a COVID-19 Biomarker: Using a Smartphone to Monitor Symptoms and Disease Progression

Medopad is prioritising R&D efforts for novel technologies that could help reduce the spread and management of COVID-19. Medopad is collaborating with Johns Hopkins and key opinion leaders from Imperial College and other major academic partners to fast-track the development and validation of a digital biomarker to determine an individual risk profile for COVID-19.

“We have been working in collaboration with Medopad for over a year on a digital biomarker project. COVID-19 presents an opportunity for us to take this work further and develop a specific COVID-19 digital biomarker. The aim is to adjust the data points collected and focus specifically on cardio-respiratory diseases, diabetes and other conditions which compromise the immune system to identify those who are most at risk should they contract COVID-19,” added Alain Labrique, Associate Professor at Johns Hopkins Bloomberg School of Public Health.

Medopad is also developing a way to use a smartphone’s gyroscope-powered motion sensors to accurately measure an individual’s heart and respiratory rate without the need for additional hardware by placing a phone on the patient’s chest wall for 30-60 seconds. Developing and validating this digital biomarker, combined with other data points, will enable more efficient COVID-19 patient monitoring and clinical team support by remotely tracking vital signs that indicate the severity of COVID-19.

Dan Vahdat, founder and CEO of Medopad, commented, “This is an unprecedented global health crisis that requires a global response. To do our part, Medopad is providing our platform and development efforts to aid in the fight of the COVID-19 pandemic. We have already had initial success detecting digital biomarkers for rare and chronic diseases like Parkinson’s, Alzheimer’s and are now shifting most of our resources towards COVID-19 efforts. Now is the time for global collaboration to help ease the burden of COVID-19 on our healthcare systems, reduce disease spread through remote patient monitoring and maintain the continuity of care for at-risk populations.”

Medopad is conducting feasibility studies and clinical trials to validate its digital biomarkers for detecting and assessing diseases and health conditions such as Parkinson’s with partners including Tencent, J&J, Bayer and more. It is now working with partners including Johns Hopkins and Tencent to fast-track the development and validation of a specific digital biomarker for COVID-19 using only a smartphone.

“The joint Medopad and Tencent Medical AI lab have been working for the last 2 years on various digital biomarker projects. COVID-19 presents an opportunity for us to modify some of our R&D work to showcase the power of using smartphones and simple devices to capture data directly from patients and the population at large and generating novel insights from it. Together with our academic partners, we are working on a number of digital biomarkers which can be done with only a smartphone to help unlock valuable data to better understand and treat COVID-19. While moving at pace, we continue to work closely with regulators and design our technology to maximise data privacy,” and Dr. David Wei Fan, Executive Director of Tencent Medical AI Lab.

About Medopad

Medopad is a global health technology company that aims to use data and technology to give everyone the full picture of patients’ health to help people live longer, fuller lives. Medopad partners with the world’s largest healthcare systems, pharma companies, research institutes, insurers and technology companies like Apple and Tencent to create a connected health ecosystem that empowers patients, improves clinical outcomes and enables the future of healthcare. http://www.medopad.com

Share article on social media or email:

Study offers potential breakthrough in the war on antibiotic-resistant superbugs


Gerlinde R. Van de Walle, DVM, Ph.D., co-lead for the study.

Researchers have potentially made a breakthrough in the war on antibiotic-resistant superbugs – including MRSA, which kills an estimated 20,000 people in the United States alone each year – with a new discovery whose details are published today in STEM CELLS Translational Medicine. The study, by researchers at The Baker Institute for Animal Health, at Cornell’s College of Veterinary Medicine, demonstrates for the first time that mesenchymal stromal cells (MSCs) are an effective weapon against bacteria in biofilm.

Biofilms are thin, slimy films made up of bacteria that can attach to skin wounds, teeth and other surfaces, creating the opportunity for infections to flourish. These highly structured cellular communities offer bacteria shelter from harmful factors, helping them resist antibiotics, mutate rapidly and evade the immune system.

“MSCs help kill the bacteria through the secretion of enzymes, called proteases, that break the peptide bonds of proteins and cause biofilm to destabilize. This in turn increases the effectiveness of antibiotics that previously weren’t working, as the bacteria are no longer being protected by the biofilm,” explained Gerlinde R. Van de Walle, DVM, Ph.D., who led the study along with Charlotte Marx, DVM, Ph.D.

Other recent studies, including one by the Cornell team, have shown that MSCs can inhibit the growth of bacteria associated with chronic infections by secreting antimicrobial peptides. “But these studies were conducted primarily on planktonic bacteria, which are individually floating bacteria cells. Thus, information on the effects on biofilms was largely lacking,” Dr. Marx said.

The current study explores how MSC secretome, delivered as conditioned medium, performs against various wound-related bacterial pathogens. It also looks at the mechanisms that affect bacterial biofilms. The experiments were performed in vitro, using equine MSC. “We use equine MSC in our work since the horse represents a physiologically relevant model for human wound healing and offers a readily translatable model for MSC therapies in humans,” Dr. Van de Walle explained.

The researchers began by showing that equine MSC secretome inhibits the growth of four types of planktonic bacteria that commonly colonize skin wounds. Encouraged by the results, they next sought to determine the effect of the MSC secretome on these same bacterial strains in biofilms, which is the predominant way bacteria invade wounds. They looked at how the MSCs affected biofilm formation, then repeated the experiments on biofilms that were already established. Finally, they turned their attention to the bacteria strain responsible for MRSA.

Dr. Marx reported the results. “Our salient findings,” she said, “were that factors secreted by equine MSC impaired both planktonic and biofilms — including MRSA — as well as disrupted mature biofilms generated by these bacteria. Importantly, we found that these effects resulted from a protease-dependent mechanism.”

Dr. Van de Walle added, “We also found that MSC-secreted factors allowed previously ineffective antibiotic treatments to become more effective at reducing bacterial survival. In light of the rise of antibiotic-resistant bacterial strains as an increasing global health threat, our findings provide the rationale for using the MSC secretome as a complementary treatment for bacterial infections.”

“Outcomes from this study highlight for the first time that the secretome from mesenchymal stem cells significantly reduces the formation of bacterial infections, including the antibiotic resistant MRSA,” said Anthony Atala, M.D., Editor-in-Chief of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine. “Antibiotic resistance has long been a concern and this research highlights some promising new tactics.”

###

The full article, “The mesenchymal stromal cell (MSC) secretome impairs methicillin-resistant S. aureus (MRSA) biofilms via cysteine protease activity in the equine model,” can be accessed at https://stemcellsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/sctm.19-0333.

About STEM CELLS Translational Medicine: STEM CELLS Translational Medicine (SCTM), co-published by AlphaMed Press and Wiley, is a monthly peer-reviewed publication dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices. SCTM is the official journal partner of Regenerative Medicine Foundation.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes two other internationally renowned peer-reviewed journals: STEM CELLS® (http://www.StemCells.com), celebrating its 38th year, is the world’s first journal devoted to this fast paced field of research. The Oncologist® (http://www.TheOncologist.com), also a monthly peer-reviewed publication, entering its 25th year, is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. All three journals are premier periodicals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines.

About Wiley: Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical and scholarly journals, combined with our digital learning, assessment and certification solutions, help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company’s website can be accessed at http://www.wiley.com.

About Regenerative Medicine Foundation (RMF): The non-profit Regenerative Medicine Foundation fosters strategic collaborations to accelerate the development of regenerative medicine to improve health and deliver cures. RMF pursues its mission by producing its flagship World Stem Cell Summit, honouring leaders through the Stem Cell and Regenerative Medicine Action Awards, and promoting educational initiatives.

CHESS Health Measures Record App Usage During COVID-19 Crisis


CHESS Health, the leading provider of addiction management technology, today announced record usage for its patient-facing Connections app during the COVID-19 pandemic and the release of its new functionality to support growing use of telehealth. Isolation caused by the need for social distancing has resulted in cancellations of in-person treatment programs and 12-Step recovery meetings on a national (and global) basis, leaving many without the connection and support needed to maintain healthy recovery and avoid life-threatening relapse.

“Due to the COVID-19 pandemic those struggling with substance use disorder (SUD) will be faced with new obstacles as they quarantine from jobs, friends and peers in recovery,” said Hans Morefield, chief executive officer of CHESS Health. “The Connections app offers digital access to support, peers, motivating content, and digital eTherapy necessary to keep SUD patients connected and confident in their recovery in this stressful time.”

Usage of the Connections app is up 150% week-over-week and new patient enrollment increased 34% during the same period. One individual shared: “I am loving this app. It’s very helpful to have all these great messages while I’m teleworking and at home!”

“Our new telehealth coordination and communication functionality addresses a challenge we’re hearing from providers using Zoom and Google Hangouts –how to best tell groups and individual patients about telehealth sessions without re-keying all of our patient data into a video platform, “explained Morefield. “Our customers already use CHESS to communicate with their groups and patients, including pushing appointments and reminders, so it was a natural extension for us to add functionality to help coordinate and communicate telehealth sessions through multiple channels.”

To get more information about the CHESS platform, eRecovery and the Connections app please visit http://www.chess.health/eRecovery/.

About CHESS Health

CHESS Health is the developer of the leading, evidence-based technology platform for the addiction management life cycle. The platform facilitates digital handoffs for getting more patients into treatment (eIntervention); improves outcomes through digital CBT (eTherapy) and reduces relapse and supports long term recovery (eRecovery). For providers, the CHESS platform grows patient volume through more successful referrals, improves treatment delivery, and measure better outcomes, including reduced relapse. Health plans and governments also benefit from more individuals in treatment and better outcomes; with the CHESS platform, they also gain analytic insights into provider performance. CHESS Health has received recognition from the Substance Abuse and Mental Health Services Administration’s National Registry of Evidence-based Programs and Practices (NREPP), the Journal of Substance Abuse and the Surgeon General. For more information, visit http://www.chess.health.

Share article on social media or email:

What Factors Should Be Analyzed Before Renewing Car Insurance


News Image

“Before renewing, spend some time analyzing what has changed since the last renewal and if you will pay more or less.” said Russell Rabichev, Marketing Director of Internet Marketing Company.

Renewing car insurance is important for any policyholder. The alternative is to switch the carrier at the right time. Otherwise, having a coverage lapse will make drivers pay more expensive premiums. Before making any change, make sure to get car insurance quotes and compare prices. Use https://compare-autoinsurance.org to get free car insurance quotes online.

There are a few things to analyze before renewing the contract:

  • Available budget. Check if the rates have increased and they are now more expensive than you can afford. If the income is the same, but the rates are higher, you should give the insurance company a call and seek ways to negotiate and an explanation of the higher premiums.
  • Look for major changes. Some major lifestyle and age changes will deeply impact the insurance premiums. Some of them can even improve the rates. Top influential changes include moving to a new neighborhood, getting married, driving less to work.
  • Traffic violations. Recent violations will surely increase the insurance costs. The company will conduct its own research before renewing and will surely find out about the wrongdoings.
  • Car modifications. If you added new parts to the car, check how the customization will impact the insurance cost. Some devices will make the car cheaper to insure, while others (usually performance boosters) will have a negative effect.

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

For more information, free quotes and money-saving tips, please visit https://compare-autoinsurance.org/.

Share article on social media or email: